Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. scores highest on Price (81) and lowest on Earnings (41). Its PosiPenta is 64.42 out of 100, better than most similar companies.
On the Penta Grid this week, Actinium Pharmaceuticals, Inc. is Grid #72 of 837 in the Healthcare sector in United States, and Grid #253 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals, Inc. | 64.42 | 81 | 41 | 66 | 78 | 55 |
| iBio, Inc. | 37.58 | 45 | 37 | 19 | 53 | 34 |
| MiNK Therapeutics, Inc. | 47.18 | 0 | 32 | 47 | 94 | 64 |
| Werewolf Therapeutics, Inc. | 39.72 | 22 | 45 | 60 | 19 | 52 |
| Rein Therapeutics Inc. | 34.66 | 13 | 37 | 25 | 59 | 39 |
| Myomo, Inc. | 37.35 | 8 | 56 | 67 | 15 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 3.23 |
| P/B ratio | 1.17 |
EEarnings
| Trailing EPS | ₹33.15 |
| Forward EPS | ₹-49.73 |
NNitro
| Price | 107.03 |
| 52-week high | 164.80 |
| 52-week low | 69.62 |
| Fall from 52-week high | 35.1% |
TTorque
| Return on equity (ROE) | 45.86% |
| Debt-to-equity | 0.04 |
AAnchor
| Beta (price swings) | 0.27 |
| Market cap | ₹336 Cr |
| Insider holding | 8.08% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Actinium Pharmaceuticals, Inc.'s PosiPenta score?
Actinium Pharmaceuticals, Inc.'s PosiPenta is 64.42 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Actinium Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Actinium Pharmaceuticals, Inc. is Grid #72 of 837 in the Healthcare sector in United States, and Grid #253 of 4,000 in United States.
Which PosiPenta pillar is strongest for Actinium Pharmaceuticals, Inc.?
Price (valuation), with a score of 81 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Actinium Pharmaceuticals, Inc.?
Earnings (growth), with a score of 41 out of 100: around the middle of similar companies.
Has Actinium Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.13 points, from 60.29 to 64.42.
PositoAI is for research and education only and is not investment advice.